Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.
Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.
复制标题
院前他汀类药物和阿司匹林使用以及严重败血症和急性肺损伤/急性呼吸窘迫综合征的患病率。
DOI:
10.1097/ccm.0b013e3182120992
复制
发表时间:
2011-06
影响因子:
8.8
通讯作者:
Ware LB
中科院分区:
文献类型:
--
作者:
O'Neal HR Jr;Koyama T;Koehler EA;Siew E;Curtis BR;Fremont RD;May AK;Bernard GR;Ware LB
To determine if prehospital statin use is associated with a lower risk of sepsis, ALI/ARDS, and mortality in critically ill patients. We also investigated the effect of combined prehospital use of both statins and aspirin. Cross-sectional analysis of a prospective cohort 575 critically ill patients admitted to the medical or surgical ICU of an academic tertiary-care hospital Of 575 patients, 149 (26%) were on statin therapy prior to hospitalization. A multivariable analysis including age, gender, current tobacco use, prehospital aspirin use, race, and APACHE II score revealed that patients on statin therapy prior to hospitalization were less likely to have or develop severe sepsis (OR 0.62, 95% CI 0.40 to 0.96) or ALI/ARDS (OR 0.60, 95% CI 0.36 to 0.99) during the first four ICU days. In-hospital mortality for patients with and without prehospital statin use (OR 1.06, 95% CI 0.62 to 1.83) was similar. Patients who had prehospital use of both statins and aspirin had the lowest rates of severe sepsis, ALI/ARDS and mortality. Prehospital use of statins may be protective against the sepsis and ALI. This effect may be potentiated by prehospital aspirin use.